(11) 98705-3426
TrademarkIQ íconeTrademarkIQ
Voltar para busca
Dado oficial do USPTO

C

Sabia que essa marca já está registrada no Estados Unidos?

Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.

Active USPTO registrationTipo: MistaEscritório: Estados Unidos

Snapshot rápido

C

ST13

US500000079265466

Classe

5, 10

Pedido

79265466

Registro

6087765

Diagnóstico de risco e oportunidade

Leitura executiva para decisão de naming, protocolo e monitoramento.

Situação USPTO

Active USPTO registration

Tipo de processo

Pedido e registro

Eventos registrados

36

Atualização mais recente

23/05/2026

Tipo de marca

Mista

Classes Nice

5, 10

Data de depósito

21/01/2019

Data de registro

30/06/2020

Data de expiração

-

Dados completos do processo

Campos estruturados da autoridade responsável e do histórico oficial.

Data da situação

30/06/2020

Última transação

23/05/2026

Escritório responsável

United States Patent and Trademark Office

Código da situação

700

Cadastro oficial

Principal Register

Código do desenho

5

Tipo de titular

16

Localização do titular

CN

Examinador

MESSICK, TABITHA LEE

Unidade examinadora

L40

Localização atual

PUBLICATION AND ISSUE SECTION

Descrição da marca

The mark consists of a stylized letter "C" consisting of three interlocking thick shaded and rounded elements.

Titulares e representantes

Titulares

CARSGEN THERAPEUTICS CO., LTD.

Representantes

Adam Bell Bell IP Law

Classificação técnica

Classes Nice

Classe 5Classe 10

Códigos Vienna

Sem códigos Vienna disponíveis.

Produtos e serviços

Classe 5

Injectable pharmaceuticals for treatment of cancer and autoimmune diseases and disorders; liquid medicine for treatment of cancer and autoimmune diseases and disorders; biological preparations for the treatment of cancer and autoimmune diseases and disorders; drug delivery agents in the form of injections for medical purposes for the treatment of cancer and autoimmune diseases and disorders; vaccine preparations; pharmaceutical preparations for cancer and immunotherapyin particular for T-cell therapy; blood for medical purposes; stem cells for medical purposes; biological tissue cultures for medical purposes; diagnostic preparations for medical purposes

Classe 10

Medical apparatus and instrumentssample preparation devices for medical diagnostic use and sample preparation devices for the treatment of cancer and autoimmune diseases and disordersapparatus for the regeneration of stem cells for medical purposes; diagnostic apparatus for medical purposes for detecting cancer and autoimmune diseases and disorders; apparatus for use in medical analysis in the fields of cancer and immunology; DNA testing apparatus for medical purposes; surgical apparatus and instruments; medical apparatus and instruments for use in otolaryngology; dental apparatus and instrumentsintra-oral light systems; uterine syringes; medical apparatus used in physiotherapy; electrodes for medical use

Publicações

Histórico de despachos e eventos da marca no USPTO.

36 publicações encontradas

ES75

TEAS SECTION 71 & 15 RECEIVED

22/05/2026

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

08/05/2026

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

08/05/2026

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

08/05/2026

REM3

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED

30/06/2025

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

14/11/2020

FICS

FINAL DISPOSITION NOTICE SENT TO IB

28/10/2020

FIMP

FINAL DISPOSITION PROCESSED

27/10/2020

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

30/09/2020

R.PR

REGISTERED-PRINCIPAL REGISTER

30/06/2020

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

14/04/2020

PUBO

PUBLISHED FOR OPPOSITION

14/04/2020

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

25/03/2020

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

07/03/2020

XAEC

EXAMINER'S AMENDMENT ENTERED

07/03/2020

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

07/03/2020

GNEA

EXAMINERS AMENDMENT E-MAILED

07/03/2020

CNEA

EXAMINERS AMENDMENT -WRITTEN

07/03/2020

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

28/02/2020

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

27/02/2020

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

27/02/2020

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

27/02/2020

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

27/02/2020

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

27/02/2020

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

27/02/2020

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

27/02/2020

RFNT

REFUSAL PROCESSED BY IB

05/10/2019

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

18/09/2019

RFRR

REFUSAL PROCESSED BY MPU

18/09/2019

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

04/09/2019

CNRT

NON-FINAL ACTION WRITTEN

03/09/2019

MAFR

APPLICATION FILING RECEIPT MAILED

03/09/2019

DOCK

ASSIGNED TO EXAMINER

30/08/2019

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

30/08/2019

LIMI

LIMITATION FROM ORIGINAL APPLICATION ENTERED

22/08/2019

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

15/08/2019

Proteção contínua da sua marca

Seja avisado a cada novo depósito que ameace C ou a sua marca.

Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.